---
company: UNITED STATES ANTIMONY CORP
ticker: UAMY
form: 8-K
filed: 2026-05-14
accession: 0001104659-26-061217
source: https://www.sec.gov/Archives/edgar/data/101538/000110465926061217/
---

# United States Antimony (UAMY) earnings release, May 14, 2026

United States Antimony Corp (UAMY) · Form 8-K, Item 2.02 · Filed 2026-05-14 · [SEC filing](https://www.sec.gov/Archives/edgar/data/101538/000110465926061217/)

United States

Antimony Corporation Reports

First Quarter

2026 Financial and Operating Results

Received $12.8

Million in Department of War (“DoW”) Grant Milestones for Thompson Falls Expansion

First Two

Delivery Notices under the $245 MM Defense Logistics Agency (“DLA”) Contract Completed

Q1 2026 Revenues of $6.8 Million; Net Loss of $11.3 Million, or $(0.08) per Diluted Share

Post-Quarter

Equity Issuances Generated $48.6 Million in Gross Proceeds

Reiterates

Full-Year 2026 Gross Revenue Guidance of $125 Million

"The

Critical Minerals and ZEO Company"

~ Antimony,

Cobalt, Gold, Tungsten, and Zeolite ~

DALLAS, TX /

ACCESS Newswire / May 14, 2026

/ United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company") (NYSE: UAMY) (NYSE Texas: UAMY), a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia, today reported its financial and operating results for the first quarter ended March 31, 2026.

First Quarter

2026 Highlights

Strategic Overview

During the first quarter of 2026, the Company continued to advance its strategy to build a fully integrated critical minerals platform supporting U.S. national security and supply chain resiliency. Key accomplishments during the quarter included the achievement of milestones under the

Company's DoW grant program, the acquisition of the Radersburg flotation mill, first delivery notice to the DLA under the $245 Million

Contract, the formation of a new hydrometallurgical joint venture with Americas Gold and Silver, and continued progress on the Thompson

Falls smelter expansion, which is nearing completion and is expected to come online over the next few weeks. The company also provided a Technical Report Summary of its Fostung Tungsten project in April 2026 reflecting future potential revenues of $4.6 Billion over the life of the property, based on the assumptions detailed in the report.

First Quarter

2026 Financial Results

Revenues for the first quarter of 2026 were $6.8 million, compared to $7.0 million in the first quarter of 2025. Antimony segment revenues were $5.6 million, compared to $5.9 million in the prior year period, with antimony pounds sold decreasing approximately 23% to 278,797 pounds from 362,647 pounds. The volume decline reflects timing of customer orders and shipments primarily, none of which were to the government. Average sales price per pound of antimony rose approximately 22% to $19.92 from $16.34.

Cost of revenues increased to $5.67 million from $4.63 million, and gross profit decreased to $1.11 million from $2.37 million in Q1 2025. Gross margin of approximately 16% (down from 34% in the prior year period) primarily reflects higher antimony cost per pound sold, which rose approximately

69% to $16.28 from $9.66 as higher-cost ore moved through cost of sales. Q1 2026 gross margin did not benefit from any of the processing of the Company’s in-house antimony mined in Montana or from any antimony deliveries under the Company's contract with the DLA.

Both of these events are expected to begin contributing during the remaining quarters of 2026 as both Montana-based mining is processed and the Thompson Falls expansion comes online.

Zeolite revenue was $1.0 million in Q1 2026 compared to $1.1 million in Q1 2025, driven by a 3% decrease in sales volume (tons sold of 3,681 versus 3,802) and 4% decrease in average sales price per ton. These sales have dramatically improved over the last sixty (60) days due to obtaining new customer relationships with the Company’s expanded sales efforts.

The Company's current antimony inventory is a combination sourced from international third-party suppliers as well as mined from the Company’s owned

Stibnite Hill, Montana mining claims. The value of our antimony inventory is approximately $21.7 million on March 31, 2026 compared to $12.0 million as of December 31, 2025 and $3.6 million as of March 31, 2025, a 80.8% increase and 502.8% increase, respectively.

Operating expenses were $8.6 million in the first quarter of 2026, compared to $2.0 million in the prior year period. The increase of $6.6 million reflects increased expense associated with the build-out of the Company's leadership team, which continues, and operational infrastructure necessary to execute the Company's vertical integration strategy. Operating expenses included approximately $4.8 million of non-cash share-based compensation expense (compared to $0.25 million in Q1 2025), reflecting expanded equity grants tied to leadership hiring and share price appreciation experienced during the period.

The Company recorded an operating loss of $7.5 million in the first quarter of 2026, compared to operating income of $0.4 million in the prior year period.

Net loss attributable to the Company was $11.3 million, or ($0.08) per diluted share, compared to net income of $0.6 million, or nil per diluted share, in the prior year period. The Q1 2026 net loss includes approximately $9.3 million of net non-cash items, comprised principally of $4.8 million of share-based compensation expense, $4.1 million of unrealized loss on the Company's investment in marketable equity securities (Larvotto Resources Limited), and $0.4 million of depreciation and amortization.

Liquidity, Capital

Resources, and Subsequent Events

At March 31,

2026, the Company had cash and cash equivalents and investments in held-to-maturity U.S. Treasury securities totaling liquid resources of $23.7 million. This compares to $30.5 million of cash and cash equivalents and $20.4 million of held-to-maturity Treasury securities at December 31, 2025. The decrease in cash during the quarter reflects $12.1 million used in operating activities (primarily working-capital... (truncated) inventory), $12.6 million used in investing activities (discussed subsequently), and $2.6 million used in financing activities (principally treasury share repurchases related to employee equity award settlements). The Company also retains a $19.0 million margin credit facility with a bank, which was undrawn at March 31, 2026.

Subsequent to March 31,

2026 and through the date of this release, the Company sold approximately 4.2 million shares of common stock at an average price of approximately

$11.57 per share, generating gross proceeds of approximately $48.6 million. These proceeds substantially offset the cash used during the first quarter to fund inventory build, the Radersburg mill acquisition, and the portion of the Thompson Falls construction in progress not yet reimbursed from the DoW.

In addition, the

Company holds an investment in publicly traded equity securities (Larvotto Resources Limited ( with a quarter-end fair value of USD $36.4 million, and a current market value as of close on May 13, 2026 of USD $46.6 million, an increase of USD $10.1 million since March 31,

2026.

Capital Expenditures and Department of Defense Grant

Capital expenditures during the first quarter of 2026 totaled $12.6 million, including $4.8 million for the acquisition of the Radersburg flotation mill in

Montana, approximately $4.6 million for the construction-in-progress expansion of the Thompson Falls antimony smelter, and approximately

$3.2 million primarily for new mineral rights acquisitions of other critical minerals.

During the first quarter, the Company achieved milestones under its Defense Production Act grant award from the DoW, resulting in formal approval by the

Defense Industrial Base Consortium for the completion of three project milestones representing $12.8 million of obligated funding. In accordance with the Company's early adoption of ASU 2025-10, Government Grants (Topic 832), effective January 1, 2026, the Company recognized the $12.8 million as a government grant receivable on the balance sheet, with a corresponding reduction to the carrying amount of construction in progress associated with the Thompson Falls expansion. According to accounting standards, the grant funding does not flow through revenue or net income; rather, it reduces the cost basis of the related long-lived assets, lowering future depreciation expense. The total DoW grant award is $27.0 million, of which $16.2 million has been obligated to date; the remaining award amount of

$10.8 million is subject to future authorization.

Operating and

Strategic Updates

During and subsequent to the first quarter, the Company made progress across its critical minerals platform:

2026 Outlook

The Company is reiterating its full-year 2026 gross revenue guidance of approximately $125 million. Achievement of this guidance is dependent on, among other factors, the timing of antimony shipments under the DoW contract, the timely commissioning of the Thompson Falls expansion during the second quarter, ramp-up of in-house antimony ore processing in both Mexico and Montana, and continued strength in critical minerals demand. The majority of full-year 2026 revenue is expected to be weighted towards the second half of the year. There can be no assurance that these factors will develop as currently anticipated; see the "Forward-Looking Statements" section below.

Management Commentary

Commenting on the first quarter 2026 results, Mr. Gary C. Evans, Chairman and Chief Executive Officer of US Antimony Corporation, stated: "When you are building a vertical business at the speed we are achieving at USAC, things rarely move in a straight line. There will be bumps in the road. Our first quarter results reflect a deliberate investment phase for our future. I told the ‘street’ during our year-end conference call that our total operating results were likely to be ‘bumpy’ this year. The increase in operating expense, the inventory build, and the capital expenditures we made in the quarter are the necessary foundation for the production scale-up we expect during the balance of 2026. While these investments drove a near-term loss, primarily all non-cash related, we believe we are much better positioned for the Company to deliver materially stronger financial performance in future reporting periods as our Montana-based mining, processing, and expanded smelting capabilities come online and integrate with our own material over the course of the year."

Mr. Evans continued: "We are particularly pleased with the progress under our DoW grant program, the addition of the Radersburg flotation mill, and the formation of our hydrometallurgical joint venture, each of which advances the vertical integration of our critical minerals platform. While government grant requests are never guaranteed, we believe our three official filings made since the first of this year, which total $274 million, are ‘on point’ and meet the standards established by these various governmental agencies in their desire to expedite ‘home grown’ critical mineral development, both in the field as well as our proprietary downstream refining processes. The positive feedback we have received to date gives us encouragement of our continued success in this endeavor. Combined with our existing DLA contract, where we have noticed the government for two deliveries, our existing pipeline of additional governmental grant requests, and the post-quarter strengthening of our balance sheet, we are well-positioned to continue executing our 2026 business plan. The additional equity capital we have raised since the end of March is to guarantee we are in a position of strength to achieve these lofty goals and objectives."

Conference Call Details

US Antimony management will host a conference call on Thursday, May 14, 2026 at 4:15 p.m. Eastern time to discuss its first quarter 2026 financial... (trating results, followed by a question-and-answer period.

Date:

Thursday, May 14,

2026

Time:

4:15 p.m. Eastern time

Toll-free dial-in:

888-506-0062

International dial-in:

973-528-0011

Participant access code:

130357

Webcast URL: https://www.webcaster5.com/Webcast/Page/2604/53986

A replay of the conference call and the transcript will be available in the Investors section of the Company's website at https://www.usantimony.com/investors.

About United States Antimony Corporation

United States Antimony

Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," "U.S. Antimony," the "Company,"

"Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S., Mexico, and Canada.

The Company mines, purchases, and processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The Company also recovers precious metals, primarily gold and silver, at its Montana facility from third-party ore. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. From 2024 through 2026, the Company has acquired mining claims, real properties (patented claims), and leases located in Alaska, Montana, and Ontario, Canada — including the Radersburg flotation mill acquired in the first quarter of 2026 — to reduce the cost of third-party antimony ore purchases and to expand its product offerings.

Learn more about

United States Antimony Corporation at www.usantimony.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company's full-year 2026 revenue guidance, the expected commissioning of the Thompson Falls smelter expansion, the expected development and contribution of the Fostung Tungsten project, the expected timing and contribution of shipments under the

DLA contract, the expected impact of in-house ore processing on margins, the recognition and continuation of funding under the DoW grant program, the expected use of post-quarter equity issuance proceeds, the application of new accounting pronouncements (including ASU 2025-10), and other statements that are not historical facts. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as management's beliefs and assumptions. Words such as "anticipates,"

"expects," "intends," "plans," "believes," "seeks," "estimates," "may,"

"will," "should," "could," and variations of these words or similar expressions are intended to identify such forward-looking statements.

Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in such statements, including, but not limited to: fluctuations in the market prices and demand for antimony and zeolite; changes in domestic and global economic conditions; operational risks inherent in mining and mineral processing; geological or metallurgical conditions; availability and cost of energy, equipment, transportation, and labor; the Company’s ability to maintain or obtain permits, licenses, and regulatory approvals; changes in environmental and mining laws or regulations; competitive factors; the impact of geopolitical developments; and the effects of weather, natural disasters, or health pandemics on operations and supply chains. Additional information regarding risk factors that could cause actual results to differ materially is included in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Contacts

UNITED

STATES ANTIMONY CORPORATION AND SUBSIDIARIES

## Financial statements

### Income Statement (Three months ended March 31, — CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED))

| | Three months ended March 31, – 2026 | Three months ended March 31, – 2025 |
|---|---:|---:|
| Revenues | 6,784,069 | 7,000,005 |
| Cost of revenues | 5,674,602 | 4,628,275 |
| Gross profit | 1,109,467 | 2,371,730 |
| Operating expenses: | General and administrative | 1,331,969 | 550,595 |
| Operating expenses: | Salaries and benefits | 5,879,794 | 1,000,555 |
| Operating expenses: | Professional fees | 1,281,131 | 382,036 |
| Operating expenses: | Gain on sale or disposal of property, plant and equipment, net | -1,900 | -500 |
| Operating expenses: | Other operating expenses | 135,668 | 81,052 |
| Operating expenses: | Total operating expenses | 8,626,662 | 2,013,738 |
| Operating expenses: | Income (loss) from operations | -7,517,195 | 357,992 |
| Other income (expense), net: | Interest and investment income | 328,288 | 192,156 |
| Other income (expense), net: | Unrealized loss on investment in equity securities | -4,061,430 |  |
| Other income (expense), net: | Other miscellaneous expense, net | -28,027 | -3,624 |
| Other income (expense), net: | Total other income (expense), net | -3,761,169 | 188,532 |
| Other income (expense), net: | Income (loss) before income taxes and equity in loss of joint venture | -11,278,364 | 546,524 |
| Other income (expense), net: | Income (loss) before equity in losses of joint venture | -11,278,364 | 546,524 |
| Other income (expense), net: | Equity in losses of joint venture | -16,126 |  |
| Other income (expense), net: | Net income (loss) | -11,294,490 | 546,524 |
| Other income (expense), net: | Preferred dividends | -1,875 | -1,875 |
| Other income (expense), net: | Net income (loss) available to common shareholders | -11,296,365 | 544,649 |
| Net income (loss) per share: | Basic | -0.08 | $nil |
| Net income (loss) per share: | Diluted | -0.08 | $nil |
| Weighted average shares outstanding: | Basic | 141,612,253 | 113,703,415 |
| Weighted average shares outstanding: | Diluted | 141,612,253 | 122,394,861 |

### Balance Sheet (March 31, 2026 — CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED))

| | March 31, 2026 | December 31, 2025 |
|---|---:|---:|
| CURRENT ASSETS | Cash and cash equivalents | 3,220,400 | 30,494,320 |
| CURRENT ASSETS | Investment in debt securities held to maturity | 4,620,170 | 4,577,706 |
| CURRENT ASSETS | Accounts receivable, net | 2,512,957 | 4,213,305 |
| CURRENT ASSETS | Government grant receivable | 12,848,246 |  |
| CURRENT ASSETS | Inventories | 22,026,820 | 12,522,009 |
| CURRENT ASSETS | Prepaid expenses and other current assets | 734,552 | 434,842 |
| CURRENT ASSETS | Note receivable | 2,445,762 | 2,500,000 |
| CURRENT ASSETS | Total current assets | 48,408,907 | 54,742,182 |
| CURRENT ASSETS | Property, plant and equipment, net | 46,668,672 | 42,374,839 |
| CURRENT ASSETS | Operating lease right-of-use assets | 38,223 | 48,106 |
| CURRENT ASSETS | Investment in debt securities held to maturity - noncurrent | 15,922,926 | 15,773,251 |
| CURRENT ASSETS | Investment in equity securities | 36,432,898 | 40,494,328 |
| CURRENT ASSETS | Investment in joint venture | 83,874 |  |
| CURRENT ASSETS | Restricted cash for reclamation bonds | 163,778 | 162,756 |
| CURRENT ASSETS | Other assets, net | 330,207 | 330,207 |
| CURRENT ASSETS | Total assets | 148,049,485 | 153,925,669 |
| CURRENT LIABILITIES | Accounts payable | 9,672,375 | 6,924,518 |
| CURRENT LIABILITIES | Accrued liabilities | 3,388,210 | 2,937,842 |
| CURRENT LIABILITIES | Accrued liabilities - directors | 140,958 | 143,931 |
| CURRENT LIABILITIES | Current portion of operating lease liabilities | 27,477 | 34,103 |
| CURRENT LIABILITIES | Current portion of long-term debt | 138,140 | 136,942 |
| CURRENT LIABILITIES | Total current liabilities | 13,367,160 | 10,177,336 |
| CURRENT LIABILITIES | Operating lease liabilities, net of current portion | 10,746 | 14,003 |
| CURRENT LIABILITIES | Long-term debt, net of current portion | 23,495 | 58,483 |
| CURRENT LIABILITIES | Asset retirement obligations | 2,753,172 | 2,720,658 |
| CURRENT LIABILITIES | Total liabilities | 16,154,573 | 12,970,480 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Series B - 750,000 shares issued and outstanding (liquidation preference $984,375 and $982,500, respectively) | 7,500 | 7,500 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Series C - 177,904 shares issued and outstanding (liquidation preference $97,847 both periods) | 1,779 | 1,779 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Common stock, $0.01 par value, 250,000,000 shares authorized; 143,738,970 and 140,042,270 shares issued, respectively | 1,437,390 | 1,400,423 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Treasury stock (699,605 and 149,639 shares of common stock at cost, respectively) | -6,372,556 | -574,153 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Additional paid-in capital | 193,603,838 | 185,608,189 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Accumulated deficit | -56,783,039 | -45,488,549 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Total stockholders' equity | 131,894,912 | 140,955,189 |
| Preferred stock $0.01 par value, 50,000,000 shares authorized: | Total liabilities and stockholders' equity | 148,049,485 | 153,925,669 |

### Cash Flow (Three months ended March 31, — CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED))

| | Three months ended March 31, – 2026 | Three months ended March 31, – 2025 |
|---|---:|---:|
| CASH FLOWS FROM OPERATING ACTIVITIES: | Net income (loss) | -11,294,490 | 546,524 |
| Adjustments to reconcile income (loss) to net cash (used in) provided by operating activities: | Depreciation and amortization | 410,459 | 281,970 |
| Adjustments to reconcile income (loss) to net cash (used in) provided by operating activities: | Accretion of asset retirement obligation | 32,514 | 19,483 |
| Adjustments to reconcile income (loss) to net cash (used in) provided by operating activities: | Noncash operating lease expense |  | 146,962 |
